PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2021-06-04

Date Title Company
04-Jun-2021 What are the Opportunities in the Sterilants Market? MARKITWIRED
04-Jun-2021 Demand for Wearable Therapeutic Devices Accounts for over 50% of Wearable Devices Market Share MARKITWIRED
04-Jun-2021 Global Urinary Bag Market will rise at a CAGR of 4.4% CAGR between 2021 and 2031 MARKITWIRED
04-Jun-2021 Puma Biotechnology Presents Data from the EGFR Exon 18-mutant NSCLC Cohort of the Phase II SUMMIT Trial at the 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 Puma Biotechnology Presents Data Comparing Findings from the Phase II CONTROL Trial with the Neratinib Arm of the Phase III ExteNET Trial at the ASCO 2021 Annual Meeting Businesswire
04-Jun-2021 Sleep Apnea Devices Industry – Global Revenue Growth Predictions MarketsandMarkets Research Private Ltd.
04-Jun-2021 How will Initiatives in Creating Awareness Influence Ophthalmic Eye Drops Demand? MARKITWIRED
04-Jun-2021 Puma Biotechnology Presents Data from the Phase III ExteNET Trial in Early Stage HER2-Positive Breast Cancer Patients at the Virtual 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 BeiGene Presents Clinical Data from Two Pivotal Trials of Tislelizumab at the 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 Lyvgen Biopharma Presents Clinical Trial Data of CD137/4-1BB Agonistic Antibody LVGN6051 at the 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 Exelixis Announces Positive Phase 2 Results for CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) in Patients with Metastatic Non-Clear Cell Renal Cell Carcinoma at ASCO 2021 Businesswire
04-Jun-2021 Exelixis Announces Consistent Efficacy Benefits Across Subgroups of Phase 3 CheckMate -9ER Trial of CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) as a First-line Treatment for Patients with Advanced Renal Cell Carcinoma Businesswire
04-Jun-2021 BeiGene Presents Clinical Data from Two Phase 2 Trials of Pamiparib at the 2021 ASCO Annual Meeting Businesswire
04-Jun-2021 Magenta Therapeutics Announces Additional Preliminary Positive Results from Ongoing Phase 2 Clinical Trial of MGTA-145 and Plerixafor in Patients with Multiple Myeloma at the American Society of Clinical Oncology (ASCO) Annual Meeting Businesswire
04-Jun-2021 Exelixis Announces Quality-Adjusted Survival Benefit Demonstrated in Analysis of Phase 3 CheckMate -9ER Trial of CABOMETYX® (cabozantinib) in Combination with OPDIVO® (nivolumab) in Patients with Previously Untreated Advanced Renal Cell Carcinoma Businesswire
04-Jun-2021 Healthcare IT Market - Global Industry is Expecting a Major Makeover in Near Future MarketsandMarkets Research Private Ltd.
04-Jun-2021 Historical Trends Positive, But Future Outlook Even Brighter for Organoids Market MARKITWIRED
04-Jun-2021 How are Aesthetic Surgeries Driving Laser Therapy Devices Demand? MARKITWIRED
04-Jun-2021 Global HbA1c Testing Market 2021:Growth Analysis,Developments, Key Business Strategies,Outlook,Forecast To 2028||Players-Danaher, F. Hoffmann-La Roche Ltd., Siemens Healthcare GmbH, TransAsia Bio-Medicals, Trinity Biotech Ireland CDN Newswire
04-Jun-2021 API Market – This is How Pandemic Has Affected the Global API Manufacturing MarketsandMarkets Research Private Ltd.